Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with IpilimumabCurr Oncol 2022 Oct 14;29(10)7695-7704, S Goutam, I Stukalin, B Ewanchuk, M Sander, PQ Ding, DE Meyers, D Heng, WY Cheung, T Cheng
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.